+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Biopharmaceutical Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • PDF Icon


  • 195 Pages
  • February 2024
  • Region: Global
  • Infogence Global Research
  • ID: 5397295
The Global Biopharmaceutical Market is estimated to be USD 391.8 Bn in 2023 and is expected to reach USD 566.68 Bn by 2028 growing at a CAGR of 7.66%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviours of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

  • The Global Biopharmaceutical Market is segmented based on Product Type, Therapeutic Application, and Geography.
  • By Product Type, the market is classified into monoclonal antibodies, recombinant growth factors, purified proteins, recombinant proteins, recombinant hormones, vaccines, synthetic immunomodulators, recombinant enzymes, cell and gene therapies, and others.
  • By Therapeutic Application, the market is classified into oncology, cardiology, neurology, autoimmune disorders, hormonal disorders, and others.
  • By Geography, the market is classified into Americas, Europe, Middle East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Abbott Laboratories, Amgen Inc, Beijing SL Pharmaceutical Co. Ltd., etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

  • The report presents a detailed Ansoff matrix analysis for the Global Biopharmaceutical Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
  • The publisher analyses the Global Biopharmaceutical Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
  • Based on the SWOT analysis conducted on the industry and industry players, the publisher has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Biopharmaceutical Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth Market analysis using Porter's 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 and the impact of economic slowdown & impending recession on the Market are also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the Proprietary competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook
4 Market Dynamics
4.1 Drivers
4.1.1 Increases in Prevalence of Chronic Diseases
4.1.2 Surges in Demand for Biopharmaceutical Medicines
4.2 Restraints
4.2.1 Stringent Government Regulations
4.2.2 High-end Manufacturing Requirements
4.3 Opportunities
4.3.1 Increasing Investments in Research and Development
4.3.2 Rising Adoption in Emerging Economies
4.4 Challenges
4.4.1 Lack of Skilled Personnel
5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 PESTLE Analysis
5.4 SWOT Analysis
5.5 Impact of COVID-19
5.6 Impact of Economic Slowdown & Impending Recession
5.7 Ansoff Matrix Analysis
6 Global Biopharmaceutical Market, By Product Type
6.1 Introduction
6.2 Monoclonal Antibodies
6.2.1 Anti-cancer Monoclonal Antibodies
6.2.2 Anti-inflammatory Monoclonal Antibodies
6.2.3 Other Monoclonal Antibodies
6.3 Recombinant Growth Factors
6.3.1 Erythropoietin
6.3.2 Granulocyte Colony Stimulating Factor
6.4 Purified Proteins
6.4.1 Leukemia Inhibitory Factor (LIF)
6.4.2 P53 Protein
6.4.3 P38 Protein
6.4.4 Other Purified Proteins
6.5 Recombinant Proteins
6.5.1 Serum Albumin
6.5.2 Amyloid Protein
6.5.3 Defensin
6.5.4 Transferrin
6.6 Recombinant Hormone
6.6.1 Recombinant Human Growth Hormones
6.6.2 Recombinant Insulin
6.6.3 Other Recombinant Hormones
6.7 Vaccines
6.7.1 Recombinant Vaccines
6.8 Cancer Vaccines
6.8.1 Conventional Vaccines
6.8.2 Cytokines
6.8.3 Interferons
6.8.4 Interleukins
6.9 Recombinant Enzymes
6.9.1 Enterokinase
6.9.2 Cyclase
6.9.3 Caspase
6.9.4 Cathepsin
6.10 Cell and Gene Therapies
6.10.1 Allogenic Products
6.10.2 Autologous Products
6.10.3 Acellular Products
6.11 Others
6.11.1 Blood Factors
6.11.2 Other Product Types
7 Global Biopharmaceutical Market, By Therapeutic Application
7.1 Introduction
7.2 Oncology
7.3 Cardiology
7.4 Neurology
7.5 Autoimmune Disorders
7.6 Hormonal Disorders
7.7 Others
8 Americas' Biopharmaceutical Market
8.1 Introduction
8.2 Argentina
8.3 Brazil
8.4 Canada
8.5 Chile
8.6 Colombia
8.7 Mexico
8.8 Peru
8.9 United States
8.10 Rest of Americas
9 Europe's Biopharmaceutical Market
9.1 Introduction
9.2 Austria
9.3 Belgium
9.4 Denmark
9.5 Finland
9.6 France
9.7 Germany
9.8 Italy
9.9 Netherlands
9.10 Norway
9.11 Poland
9.12 Russia
9.13 Spain
9.14 Sweden
9.15 Switzerland
9.16 United Kingdom
9.17 Rest of Europe
10 Middle East and Africa's Biopharmaceutical Market
10.1 Introduction
10.2 Egypt
10.3 Israel
10.4 Qatar
10.5 Saudi Arabia
10.6 South Africa
10.7 United Arab Emirates
10.8 Rest of MEA
11 APAC's Biopharmaceutical Market
11.1 Introduction
11.2 Australia
11.3 Bangladesh
11.4 China
11.5 India
11.6 Indonesia
11.7 Japan
11.8 Malaysia
11.9 Philippines
11.10 Singapore
11.11 South Korea
11.12 Sri Lanka
11.13 Thailand
11.14 Taiwan
11.15 Rest of Asia-Pacific
12 Competitive Landscape
12.1 Competitive Quadrant
12.2 Market Share Analysis
12.3 Strategic Initiatives
12.3.1 M&A and Investments
12.3.2 Partnerships and Collaborations
12.3.3 Product Developments and Improvements
13 Company Profiles
13.1 Abbott Laboratories
13.2 Amgen Inc
13.3 Beijing SL Pharmaceutical Co. Ltd.
13.4 Biocon Ltd
13.5 Biological E Ltd.
13.6 Cadila Healthcare Limited (Zydus Cadila)
13.7 Celltrion, Inc
13.8 Eli Lilly and Company
13.9 F. Hoffmann-La Roche Ltd.
13.10 Glenmark Pharmaceuticals Ltd.
13.11 GVK Biosciences Pvt Ltd
13.12 Hualan Biological Engineering Inc
13.13 Johnson & Johnson
13.14 Merck & Co., Inc
13.15 Novo Nordisk A/S
13.16 Pfizer Inc.
13.17 Reliance Life Sciences Pvt. Ltd.
13.18 RPG Life Sciences Ltd.
13.19 Samsung Biologics Co. Ltd.
13.20 Sanofi S.A.
13.21 Shanghai Institute of Biological Products
13.22 Shantha Biotechnics Ltd.
13.23 Sun Pharmaceutical Industries Ltd
13.24 Suven Life Sciences Ltd
13.25 Takeda Pharmaceutical Co. Ltd.
13.26 Torrent Pharmaceuticals Ltd.
14 Appendix
14.1 Questionnaire

Companies Mentioned

  • Abbott Laboratories
  • Amgen Inc
  • Beijing SL Pharmaceutical Co. Ltd.
  • Biocon Ltd
  • Biological E Ltd.
  • Cadila Healthcare Ltd. (Zydus Cadila)
  • Celltrion, Inc
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • GVK Biosciences Pvt Ltd
  • Hualan Biological Engineering Inc
  • Johnson & Johnson
  • Merck & Co., Inc
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Reliance Life Sciences Pvt. Ltd.
  • RPG Life Sciences Ltd.
  • Samsung Biologics Co. Ltd.
  • Sanofi S.A.
  • Shanghai Institute of Biological Products
  • Shantha Biotechnics Ltd.
  • Sun Pharmaceutical Industries Ltd
  • Suven Life Sciences Ltd
  • Takeda Pharmaceutical Co. Ltd.
  • Torrent Pharmaceuticals Ltd.

Table Information